Identifying high-risk medication: A systematic literature review

European Journal of Clinical Pharmacology

Volumn 70, Issue 6, 2014, Pages 637-645

  Saedder, Eva A ^a   Brock, Birgitte ^a   Nielsen, Lars Peter ^a   Bonnerup, Dorthe K ^a   Lisby, Marianne ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Adverse reactions; High risk drugs; Medication errors; Medication review

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMIODARONE; ANTINEOPLASTIC AGENT; DIGOXIN; HEPARIN; LOOP DIURETIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; METHOTREXATE; NITROFURANTOIN; OPIATE; PROTEINASE INHIBITOR; THEOPHYLLINE; THIAZIDE DIURETIC AGENT; WARFARIN; DRUG;

ADVERSE DRUG REACTION; AFRICA; AUSTRALIA; BIRTH DEFECT; DATA BASE; EMBASE; EUROPE; FOOD AND DRUG ADMINISTRATION; HOSPITALIZATION; HUMAN; MEDICATION ERROR; MEDLINE; NEW ZEALAND; PRIORITY JOURNAL; PSYCINFO; REVIEW; SYSTEMATIC REVIEW; UNITED STATES; CLASSIFICATION; DRUG SURVEILLANCE PROGRAM; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; STATISTICS AND NUMERICAL DATA;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HOSPITALIZATION; HUMANS; MEDICATION ERRORS; PHARMACEUTICAL PREPARATIONS;

EID: 84901686995     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-014-1668-z     Document Type: Review

References (87)

1. Guideline on good pharmacovigilance practices - Module VI. Management and reporting of adverse reactions to medicinal products.(2012). In: http://www.ema.europa.eu/ema/index.jsp?curl=pages/special-topics/general/ general-content-000570.jsp. Accessed 12/18 2013
2. Clinical safety data management: Definitions and standards for expedited reporting E2A. In: www.ich.org. Accessed July/04 2013
3. Lisby M, Nielsen LP, Brock B, Mainz J (2012) How should medication errors be defined? Development and test of a definition. Scand J Public Health 40:203-210
4. Krahenbuhl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krahenbuhl S (2007) Drug-related problems in hospitals: a review of the recent literature. Drug Saf 30:379-407
5. Lewis PJ, Dornan T, Taylor D, Tully MP, Wass V, Ashcroft DM (2009) Prevalence, incidence and nature of prescribing errors in hospital inpatients: a systematic review. Drug Saf 32:379-389
6. Rehan HS, Chopra D, Kakkar AK (2009) Physician's guide to pharmacovigilance: terminology and causality assessment. Eur J Int Med 20:3-8
7. Christensen M, Lundh A (2013) Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev 2:CD008986
8. O'Connor MN, Gallagher P, O'Mahony D (2012) Inappropriate prescribing: criteria, detection and prevention. Drugs Aging 29:437-452
9. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 151:1825-1832
10. Naugler CT, Brymer C, Stolee P, Arcese ZA (2000) Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol 7:103-107
11. Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, Cohen HJ, Feussner JR (1992) A method for assessing drug therapy appropriateness. J Clin Epidemiol 45:1045-1051
12. Samsa GP, Hanlon JT, Schmader KE, Weinberger M, Clipp EC, Uttech KM, Lewis IK, Landsman PB, Cohen HJ (1994) A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 47:891-896
13. Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D (2008) STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 46:72-83
14. Barry PJ, Gallagher P, Ryan C, O'mahony D (2007) START (screening tool to alert doctors to the right treatment)-an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 36:632-638
15. Marriott J, Stehlik P (2012) A critical analysis of the methods used to develop explicit clinical criteria for use in older people. Age Ageing 41:441-450
16. Hill-Taylor B, Sketris I, Hayden J, Byrne S, O'Sullivan D, Christie R (2013) Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther
17. Gallagher PF, O'Connor MN, O'Mahony D (2011) Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 89:845-854
18. Agency for Patients' Rights and Complaints. In: www.patientombuddet.dk 2011
19. The Patient Insurance Association. In: www.patientforsikringen.dk 2011
20. The Danish Patient Safety Database. In: www.dpsd.dk 2011
21. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30: 239-245
22. Wulff HR (1981) Mortality in small hospitals. Ugeskr Laeger 143: 130-131
23. WHO Collaborating Centre for Drug Statistics Methodology. In: http://www.whocc.no/ 2013
24. Moore TJ, Walsh CS, Cohen MR (2004) Reported medication errors associated with methotrexate. Am J Health Syst Pharm 61:1380-1384
25. Avery JK (2006) Be careful about what you sign. J Ark Med Soc 102:290
26. Sinicina I, Mayr B, Mall G, Keil W (2005) Deaths following methotrexate overdoses by medical staff. J Rheumatol 32:2009-2011
27. Saravana S, Lalukotta K (2003) Myelotoxicity due to methotrexate - an iatrogenic cause. Eur J Haematol 71:315-316
28. Vesseur J, Feenstra J (1996) Methotrexate; fatal dosage errors due to inattention]. Ned Tijdschr Geneeskd 140:1533-1535
29. Ferner RE, Whittington RM (1994) Coroner's cases of death due to errors in prescribing or giving medicines or to adverse drug reactions: Birmingham 1986-1991. J R Soc Med 87:145-148
30. Jonsson AK, Hakkarainen KM, Spigset O, Druid H, Hiselius A, Hagg S (2010) Preventable drug related mortality in a Swedish population. Pharmacoepidemiol Drug Saf 19:211-215
31. Cobaugh DJ, Krenzelok EP (2006) Adverse drug reactions and therapeutic errors in older adults: a hazard factor analysis of poison center data. Am J Health Syst Pharm 63:2228-2234
32. Reardon M, Burns B, Brewer B, O'Sullivan JP (1995) Deaths associated with warfarin in elderly patients. Br J Clin Pract 49:322-323
33. Bird S (2003) Medication errors-warfarin. Aust Fam Physician 32: 1003-1004
34. Buajordet I, Ebbesen J, Erikssen J, Brors O, Hilberg T (2001) Fatal adverse drug events: the paradox of drug treatment. J Intern Med 250: 327-341
35. Fentanyl patches: Preventable overdose (2010) Prescr Int 19:22-25
36. Hicks RW, Sikirica V, Nelson W, Schein JR, Cousins DD (2008) Medication errors involving patient-controlled analgesia. Am J Health Syst Pharm 65:429-440
37. Ferner RE (2000) Medication errors that have led to manslaughter charges. BMJ 321:1212-1216
38. Raschetti R, Morgutti M, Menniti-Ippolito F, Belisari A, Rossignoli A, Longhini P, La Guidara C (1999) Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 54:959-963
39. Zoppi M, Braunschweig S, Kuenzi UP, Maibach R, Hoigne R (2000) Incidence of lethal adverse drug reactions in the comprehensive hospital drug monitoring, a 20-year survey, 1974-1993, based on the data of Berne/St. Gallen. Eur J Clin Pharmacol 56:427-430
40. Green CF, Mottram DR, Rowe PH, Pirmohamed M (2000) Adverse drug reactions as a cause of admission to an acutemedical assessment unit: a pilot study. J Clin Pharm Ther 25:355-361
41. Hopf Y, Watson M, Williams D (2008) Adverse-drug-reaction related admissions to a hospital in Scotland. Pharm World Sci 30: 854-862
42. Gurwitz JH, Field TS, Judge J, Rochon P, Harrold LR, Cadoret C, Lee M, White K, LaPrino J, Erramuspe-Mainard J, DeFlorio M, Gavendo L, Auger J, Bates DW (2005) The incidence of adverse drug events in two large academic long-term care facilities. Am J Med 118:251-258
43. Kuehm SL, Doyle MJ (1990) Medication errors: 1977 to,1988. Experience in medical malpractice claims. N J Med 87:27-34
44. Schiff GD, Hegde HK, LaCloche L, Hryhorczuk DO (1991) Inpatient theophylline toxicity: preventable factors. Ann Intern Med 114:748-753
45. Deters M, Prasa D, Hentschel H, Schaper A (2009) Iatrogenic intravenous medication errors reported to the GIZ-Nord Poisons Center Gottingen. Eur J Int Med 20:728-731
46. van Doormaal JE, van den Bemt PM, Mol PG, Zaal RJ, Egberts AC, Haaijer-Ruskamp FM, Kosterink JG (2009) Medication errors: the impact of prescribing and transcribing errors on preventable harm in hospitalised patients. Qual Saf Health Care 18:22-27
47. Erlbeck A (2003) Error in drug prescription. Prescription for NSAR until the patient bleeds to death]. MMW Fortschr Med 145:15
48. Ridley-Smith RM (2007) A fatal error. N Z Med J 120:U2570
49. Sessler CN (1990) Theophylline toxicity: clinical features of 116 consecutive cases. Am J Med 88:567-576
50. Hallas J, Harvald B, Gram LF, Grodum E, Brosen K, Haghfelt T, Damsbo N (1990) Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 228:83-90
51. Howard RL, Avery AJ, Howard PD, Partridge M (2003) Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care 12:280-285
52. Cooke DI, van der Merwe W, Pudifin DJ (1985) Hospital admissions for adverse reactions to drugs and deliberate self-poisoning. S Afr Med J 67:770-772
53. Lammle B (2003) Clinical problems with oral anticoagulation - 3 case reports. Ther Umsch 60:63-66
54. Whipple JK, Ausman RK, Quebbeman EJ (1992) Narcotic use in the hospital: reasonably safe? Ann Pharmacother 26:897-901
55. Kaboli PJ, Glasgow JM, Jaipaul CK, Barry WA, Strayer JR, Mutnick B, Rosenthal GE (2010) Identifying medication misadventures: poor agreement among medical record, physician, nurse, and patient reports. Pharmacotherapy 30:529-538
56. Elsayem A, Bruera E (2005)Methadone-induced respiratory depression in a patient with a history of alcoholism. J Palliat Med 8:1062-1066
57. Pharmaceutical drug overdose case reports: from the world literature (2004) Toxicol Rev 23:59-63
58. Holt DW, Kundu BC, Forecast DJ (1978) Hospital admissions due to therapeutic overdosage with digoxin. Practitioner 221:627-630
59. Odar-Cederlof I, Oskarsson P, Ohlen G, Tesfa Y, Bergendal A, Hellden A, Bergman U (2008) Adverse drug effect as cause of hospital admission. Common drugs are the major part according to the cross-sectional study. Lakartidningen 105:890-893
60. McDonnell PJ, Jacobs MR (2002) Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 36: 1331-1336
61. Frankl SE, Breeling JL, Goldman L (1991) Preventability of emergent hospital readmission. Am J Med 90:667-674
62. Hallas J, Haghfelt T, Gram LF, Grodum E, Damsbo N (1990) Drug related admissions to a cardiology department; frequency and avoidability. J Intern Med 228:379-384
63. Bedell SE, Deitz DC, Leeman D, Delbanco TL (1991) Incidence and characteristics of preventable iatrogenic cardiac arrests. JAMA 265: 2815-2820
64. Hardmeier B, Braunschweig S, Cavallaro M, Roos M, Pauli-Magnus C, Giger M, Meier PJ, Fattinger K (2004) Adverse drug events caused by medication errors in medical inpatients. Swiss Med Wkly 134:664-670
65. van der Linden CM, Jansen PA, van Marum RJ, Grouls RJ, Korsten EH, Egberts AC (2010) Recurrence of adverse drug reactions following inappropriate re-prescription: better documentation, availability of information and monitoring are needed. Drug Saf 33:535-538
66. Rogers S, Wilson D, Wan S, Griffin M, Rai G, Farrell J (2009) Medication-related admissions in older people: a cross-sectional, observational study. Drugs Aging 26:951-961
67. Leclercq V, Lacaille S, Delpierre S, Karoubi E, Legrain S (2005) Avoidable adverse event: carbamazepine encephalopathy when introducing clarithromycine. Rev Med Interne 26:835-836
68. Miller A, Price G (2009) Gabapentin toxicity in renal failure: The importance of dose adjustment. Pain Med (USA) 10:190-192
69. Jonville-Bera AP, Saissi H, Bensouda-Grimaldi L, Beau-Salinas F, Cissoko H, Giraudeau B, Autret-Leca E (2009) Avoidability of adverse drug reactions spontaneously reported to a French regional drug monitoring centre. Drug Saf 32:429-440
70. Frankfort SV, Tulner LR, Knol W, van Campen JP, Schellens JH, Beijnen JH (2004) Prescription error resulting in valproic acid intoxication. J Am Geriatr Soc 52:2142-2143
71. Ajdukovic M, Crook M, Angley C, Stupans I, Soulsby N, Doecke C, Anderson B, Angley M (2007) Pharmacist elicited medication histories in the Emergency Department: Identifying patient groups at risk of medication misadventure. Pharm Pract 5:162-168
72. Nuckols TK, Bower AG, Paddock SM, Hilborne LH, Wallace P, Rothschild JM, Griffin A, Fairbanks RJ, Carlson B, Panzer RJ, Brook RH (2008) Programmable infusion pumps in ICUs: an analysis of corresponding adverse drug events. J Gen Intern Med 23(Suppl 1): 41-45
73. Makeham MA, Saltman DC, Kidd MR (2008) Lessons from the TAPS study. Warfarin: a major cause of threats to patient safety. Aust Fam Physician 37:817-818
74. Wilson JS Jr (2008) Coumadin therapy: loaded for bear without strong guidelines in place. J Med Assoc Georgia 97:34-36
75. Paul E, End-Rodrigues T, Thylen P, Bergman U (2008) Adverse drug reactions a common cause of hospitalization of the elderly. A clinical retrospective study]. Lakartidningen 105:2338-2342
76. Lopez-Sanchez M, Gonzalez-Fernandez C, Valero-Diaz de Lamadrid C, Dominguez-Artiga MJ, Hernandez-Hernandez MA (2005) Enoxaparin, retroperitoneal haematoma in the elderly and impaired renal function. Anaesth Intensive Care 33:689-690
77. Benkirane RR, Abouqal R, Haimeur CC, El Kettani SECSS, Azzouzi AA, M'daghri Alaoui AA, Thimou AA, Nejmi MM, Maazouzi WW, Madani NN, R-Edwards I, Soulaymani RR (2009) Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study. J Patient Saf 5:16-22
78. Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL (1997) Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med 25:1289-1297
79. Rothschild JM, Mann K, Keohane CA, Williams DH, Foskett C, Rosen SL, Flaherty L, Chu JA, Bates DW (2007) Medication safety in a psychiatric hospital. Gen Hosp Psychiatry 29:156-162
80. Devine EB, Wilson-Norton JL, Lawless NM, Hansen RN, Hazlet TK, Kelly K, Hollingworth W, Blough DK, Sullivan SD (2007) Characterization of prescribing errors in an internal medicine clinic. Am J Health Syst Pharm 64:1062-1070
81. SSI Medicine Product Statistics in Denmark 2007-2011. In: www.medstat.dk. Accessed February/13 2014
82. Winterstein AG, Hatton RC, Gonzalez-Rothi R, Johns TE, Segal R (2002) Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports. Am J Health Syst Pharm 59:1742-1749
83. Global strategy for diagnosis, management and prevention of COPD(2013). In: http://www.goldcopd.org/Guidelines/guidelinesresources.html 2013
84. Pocket Guide for Asthma Management and Prevention(2012). In: http://www.ginasthma.org/documents/1/Pocket-Guide-for-Asthma-Management-and- Prevention 2013
85. Graabaek T, Kjeldsen LJ (2013) Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review. Basic Clin Pharmacol Toxicol 112:359-373
86. Steinman MA, Handler SM, Gurwitz JH, Schiff GD, Covinsky KE (2011) Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc 59:1513-1520
87. Salvi F, Marchetti A, D'Angelo F, Boemi M, Lattanzio F, Cherubini A (2012) Adverse drug events as a cause of hospitalization in older adults. Drug Saf 35(Suppl 1):29-45